Thirty-six weeks of once-daily, oral baricitinib was associated with greater hair regrowth on the scalp, eyebrows and ...
PTC Therapeutics could boost revenue with vatiquinone for Friedreich's ataxia. Find out why PTCT stock is poised for growth ...
As earnings season begins, filings to the SEC point to uncertainty from the current administration as potential trouble for ...
Collegium Pharmaceutical is executing on commercializing its drugs and growing sales. Click here to find out why COLL stock ...
The ruxolitinib cream met its primary end point as a treatment for prurigo nodularis in one phase 3 trial but fell short in ...
The Centers for Disease Control and Prevention (CDC) published a page on Friday listing the conflicts of interest reported by members of a key vaccine advisory committee.
Frozen mac and cheese bites were sold at grocers in Arizona and across the U.S. Here's what we know and what to do if you have them in your freezer.
Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream ...
WASHINGTON — President Donald Trump’s nominee to lead the Food and Drug Administration refused to commit to keeping access to ...
A new report from the Environmental Protection Agency found that formaldehyde presents an "unreasonable risk" to human health ...
VP at Acadia Pharmaceuticals, pled guilty to insider trading, avoiding a $1.3M loss by illicitly selling shares ahead of a ...
In this analysis presented at the American Academy of Dermatology annual meeting, serious adverse events were low, unrelated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results